107. Lee, E.C.; Park, S.-J.; Lee, S.D.; Han, S.-S.; Kim, S.H. Effects of Sarcopenia on Prognosis after Resection of Gallbladder Cancer. *J. Gastrointest. Surg.* **2020**, *24*, 1082-1091. [CrossRef]

108. Martin, L.; Gioulbasanis, I.; Senesse, P.; Baracos, V.E. Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients. *J. Parenter. Enter. Nutr.* **2020**, *44*, 227-238. [CrossRef]

109. Couderc, A.-L.; Muracciole, X.; Nouguerede, E.; Rey, D.; Schneider, S.; Champsaur, P.; Lechevallier, E.; Lalys, L.; Villani, P. HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate Cancer. *J. Nutr. Health Aging* **2020**, *24*, 205-209. [CrossRef]

110. He, W.-Z.; Jiang, C.; Liu, L.-L.; Yin, C.-X.; Rong, Y.-M.; Hu, W.-M.; Yang, L.; Wang, L.; Jin, Y.-N.; Lin, X.-P.; et al. Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer. *Oral Oncol.* **2020**, *108*, 104771. [CrossRef]

111. Chen, X.-Y.; Li, B.; Ma, B.-W.; Zhang, X.-Z.; Chen, W.-Z.; Lu, L.-S.; Shen, X.; Zhuang, C.-L.; Yu, Z. Sarcopenia is an effective prognostic indicator of postoperative outcomes in laparoscopic-assisted gastrectomy. *Eur. J. Surg. Oncol.* **2019**, *45*, 1092-1098. [CrossRef]

112. Dijksterhuis, W.P.M.; Pruijt, M.J.; van der Woude, S.O.; Klaassen, R.; Kurk, S.A.; van Oijen, M.G.H.; van Laarhoven, H.W.M. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. *J. Cachexia Sarcopenia Muscle* **2019**, *10*, 199-206. [CrossRef] [PubMed]

113. Dolan, R.D.; Almasaudi, A.S.; Dieu, L.B.; Horgan, P.G.; McSorley, S.T.; McMillan, D.C. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. *J. Cachexia Sarcopenia Muscle* **2019**, *10*, 111-122. [CrossRef]

114. de Paula, N.S.; Rodrigues, C.S.; Chaves, G.V. Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer. *Eur. J. Clin. Nutr.* **2019**, *73*, 524-530. [CrossRef]

115. Griffin, O.M.; Duggan, S.N.; Ryan, R.; McDermott, R.; Geoghegan, J.; Conlon, K.C. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer. *Pancreatology* **2019**, *19*, 850-857. [CrossRef] [PubMed]

116. Hopkins, J.J.; Reif, R.L.; Bigam, D.L.; Baracos, V.E.; Eurich, D.T.; Sawyer, M.B. The Impact of Muscle and Adipose Tissue on Long-Term Survival in Patients with Stage I to III Colorectal Cancer. *Dis. Colon Rectum* **2019**, *62*, 549-560. [CrossRef]

117. Jung, A.R.; Roh, J.-L.; Kim, J.S.; Kim, S.-B.; Choi, S.-H.; Nam, S.Y.; Kim, S.Y. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer. *Eur. J. Cancer* **2019**, *116*, 98-106. [CrossRef]

118. Huillard, O.; Jouinot, A.; Tlemsani, C.; Brose, M.S.; Arrondeau, J.; Meinhardt, G.; Fellous, M.; De Sanctis, Y.; Schlumberger, M.; Goldwasser, F. Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial. *Thyroid* **2019**, *29*, 1820-1827. [CrossRef] [PubMed]

119. Kitano, Y.; Yamashita, Y.; Saito, Y.; Nakagawa, S.; Okabe, H.; Imai, K.; Komohara, Y.; Miyamoto, Y.; Chikamoto, A.; Ishiko, T.; et al. Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic Cholangiocarcinoma. *World J. Surg.* **2019**, *43*, 2271-2280. [CrossRef] [PubMed]

120. Kurk, S.; Peeters, P.; Stellato, R.; Dorresteijn, B.; de Jong, P.; Jourdan, M.; Creemers, G.; Erdkamp, F.; de Jongh, F.; Kint, P.; et al. Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients. *J. Cachexia Sarcopenia Muscle* **2019**, *10*, 803-813. [CrossRef] [PubMed]

121. Lin, J.; Zhang, W.; Chen, W.; Huang, Y.; Wu, R.; Chen, X.; Shen, X.; Zhu, G. Muscle Mass, Density, and Strength Are Necessary to Diagnose Sarcopenia in Patients with Gastric Cancer. *J. Surg. Res.* **2019**, *241*, 141-148. [CrossRef]

122. Matsunaga, T.; Miyata, H.; Sugimura, K.; Motoori, M.; Asukai, K.; Yanagimoto, Y.; Takahashi, Y.; Tomokuni, A.; Yamamoto, K.; Akita, H.; et al. Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients with Esophageal Cancer. *Anticancer Res.* **2019**, *39*, 449-458. [CrossRef] [PubMed]

123. Tamura, T.; Sakurai, K.; Nambara, M.; Miki, Y.; Toyokawa, T.; Kubo, N.; Tanaka, H.; Muguruma, K.; Yashiro, M.; Ohira, M. Adverse Effects of Preoperative Sarcopenia on Postoperative Complications of Patients with Gastric Cancer. *Anticancer Res.* **2019**, *39*, 987-992. [CrossRef]

124. Vashi, P.G.; Gorsuch, K.; Wan, L.; Hill, D.; Block, C.; Gupta, D. Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer. *PLoS ONE* **2019**, *14*, e0218761. [CrossRef] [PubMed]

125. Yamamoto, K.; Hirao, M.; Nishikawa, K.; Omori, T.; Yanagimoto, Y.; Shinno, N.; Sugimura, K.; Miyata, H.; Wada, H.; Takahashi, H.; et al. Sarcopenia Is Associated with Impaired Overall Survival after Gastrectomy for Elderly Gastric Cancer. *Anticancer Res.* **2019**, *39*, 4297-4303. [CrossRef] [PubMed]

126. Yang, J.; Zhang, T.; Feng, D.; Dai, X.; Lv, T.; Wang, X.; Gong, J.; Zhu, W.; Li, J. A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer. *Colorectal Dis.* **2019**, *21*, 538-547. [CrossRef] [PubMed]

127. Okabe, H.; Ohsaki, T.; Ogawa, K.; Ozaki, N.; Hayashi, H.; Akahoshi, S.; Ikuta, Y.; Ogata, K.; Baba, H.; Takamori, H. Frailty predicts severe postoperative complications after elective colorectal surgery. *Am. J. Surg.* **2019**, *217*, 677-681. [CrossRef] [PubMed]

128. Otten, L.; Stobäus, N.; Franz, K.; Genton, L.; Müller-Werdan, U.; Wirth, R.; Norman, K. Impact of sarcopenia on 1-year mortality in older patients with cancer. *Age Ageing* **2019**, *48*, 413-418. [CrossRef] [PubMed]
129. Panje, C.M.; Höng, L.; Hayoz, S.; Baracos, V.E.; Herrmann, E.; Garcia Schüler, H.; Meier, U.R.; Henke, G.; Schacher, S.; Hawle, H.; et al. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. *Radiat. Oncol.* **2019**, *14*, 166. [CrossRef] [PubMed]

130. Sasaki, S.; Oki, E.; Saeki, H.; Shimose, T.; Sakamoto, S.; Hu, Q.; Kudo, K.; Tsuda, Y.; Nakashima, Y.; Ando, K.; et al. Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: A pooled analysis of a multicenter clinical trial (KSCC 1605-A). *Int. J. Clin. Oncol.* **2019**, *24*, 1204–1213. [CrossRef]

131. Shi, B.; Liu, S.; Chen, J.; Liu, J.; Luo, Y.; Long, L.; Lan, Q.; Zhang, Y. Sarcopenia Is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy. *Ann. Nutr. Metab.* **2019**, *75*, 213–222. [CrossRef] [PubMed]

132. da Silva, J.R.; Wiegert, E.V.M.; Oliveira, L.; Calixto-Lima, L. Different methods for diagnosis of sarcopenia and its association with nutritional status and survival in patients with advanced cancer in palliative care. *Nutrition* **2019**, *60*, 48–52. [CrossRef] [PubMed]

133. Charette, N.; Vandeputte, C.; Ameye, L.; Bogaert, C.V.; Krygier, J.; Guiot, T.; Deleporte, A.; Delaunoit, T.; Geboes, K.; Van Laethem, J.-L.; et al. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: A post hoc analysis of two non-randomized phase II trials. *BMC Cancer* **2019**, *19*, 134. [CrossRef] [PubMed]

134. Jang, M.; Park, H.W.; Huh, J.; Lee, J.H.; Jeong, Y.K.; Nah, Y.W.; Park, J.; Kim, K.W. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI. *Eur. Radiol.* **2019**, *29*, 2417–2425. [CrossRef] [PubMed]

135. Kiss, N.; Beraldo, J.; Everitt, S. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival. *Support. Care Cancer* **2019**, *27*, 2657–2664. [CrossRef] [PubMed]

136. Kurita, Y.; Kobayashi, N.; Tokuhisa, M.; Goto, A.; Kubota, K.; Endo, I.; Nakajima, A.; Ichikawa, Y. Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy. *Pancreatology* **2019**, *19*, 127–135. [CrossRef]

137. Nakamura, N.; Ninomiya, S.; Matsumoto, T.; Nakamura, H.; Kitagawa, J.; Shiraki, M.; Hara, T.; Shimizu, M.; Tsurumi, H. Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia. *Ann. Hematol.* **2019**, *98*, 351–359. [CrossRef] [PubMed]

138. Ma, B.-W.; Chen, X.-Y.; Fan, S.-D.; Zhang, F.-M.; Huang, D.-D.; Li, B.; Shen, X.; Zhuang, C.-L.; Yu, Z. Impact of sarcopenia on clinical outcomes after radical gastrectomy for patients without nutritional risk. *Nutrition* **2019**, *61*, 61–66. [CrossRef]

139. Wang, P.; Li, Y.; Sun, H.; Zhang, R.; Liu, X.; Liu, S.; Wang, Z.; Zheng, Y.; Yu, Y.; Chen, X.; et al. Analysis of the associated factors for severe weight loss after minimally invasive McKeown esophagectomy. *Thorac. Cancer* **2019**, *10*, 209–218. [CrossRef]

140. Soma, D.; Kawamura, Y.I.; Yamashita, S.; Wake, H.; Nohara, K.; Yamada, K.; Kokudo, N. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy. *Dis. Esophagus* **2019**, *32*, doy092. [CrossRef]

141. Zhang, S.; Tan, S.; Jiang, Y.; Xi, Q.; Meng, Q.; Zhuang, Q.; Han, Y.; Sui, X.; Wu, G. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study. *Clin. Nutr.* **2019**, *38*, 2881–2888. [CrossRef]

142. Ataseven, B.; Luengo, T.G.; du Bois, A.; Waltering, K.-U.; Traut, A.; Heitz, F.; Alesina, P.F.; Prader, S.; Meier, B.; Schneider, S.; et al. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery. *Ann. Surg. Oncol.* **2018**, *25*, 3372–3379. [CrossRef] [PubMed]

143. Banaste, N.; Rousset, P.; Mercier, F.; Rieussec, C.; Valette, P.-J.; Glehen, O.; Passot, G. Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. *Int. J. Hyperth.* **2018**, *34*, 589–594. [CrossRef]

144. Chambard, L.; Girard, N.; Ollier, E.; Rousseau, J.-C.; Duboeuf, F.; Carlier, M.-C.; Brevet, M.; Szulc, P.; Pialat, J.-B.; Wegrzyn, J.; et al. Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers. *Bone* **2018**, *108*, 202–209. [CrossRef]

145. Chen, W.-Z.; Chen, X.-D.; Ma, L.-L.; Zhang, F.-M.; Lin, J.; Zhuang, C.-L.; Yu, Z.; Chen, X.-L.; Chen, X.-X. Impact of Visceral Obesity and Sarcopenia on Short-Term Outcomes after Colorectal Cancer Surgery. *Dig. Dis. Sci.* **2018**, *63*, 1620–1630. [CrossRef] [PubMed]

146. Kawamura, T.; Makuuchi, R.; Tokunaga, M.; Tanizawa, Y.; Bando, E.; Yasui, H.; Aoyama, T.; Inano, T.; Terashima, M. Long-Term Outcomes of Gastric Cancer Patients with Preoperative Sarcopenia. *Ann. Surg. Oncol.* **2018**, *25*, 1625–1632. [CrossRef] [PubMed]

147. Ní Bhuachalla, É.B.; Daly, L.E.; Power, D.G.; Cushen, S.J.; MacEneaney, P.; Ryan, A.M. Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: Is nutritional screening capturing hidden malnutrition? *J. Cachexia Sarcopenia Muscle* **2018**, *9*, 295–305. [CrossRef] [PubMed]

148. Kim, Y.R.; Park, S.; Han, S.; Ahn, J.H.; Kim, S.; Sinn, D.H.; Jeong, W.K.; Ko, J.S.; Gwak, M.S.; Kim, G.S. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria. *Sci. Rep.* **2018**, *8*, 7157. [CrossRef]

149. Lee, J.S.; Kim, Y.S.; Kim, E.Y.; Jin, W. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer. *PLoS ONE* **2018**, *13*, e0202700. [CrossRef]

150. Mayr, R.; Fritsche, H.-M.; Zeman, F.; Reiffen, M.; Siebertz, L.; Niessen, C.; Pycha, A.; van Rhijn, B.W.G.; Burger, M.; Gierth, M. Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer. *World J. Urol.* **2018**, *36*, 1201–1207. [CrossRef] [PubMed]
151. Mao, C.; Chen, X.; Lin, J.; Zhu-ge, W.; Xie, Z.; Chen, X.; Zhang, F.; Wu, R.; Zhang, W.; Lou, N.; et al. A Novel Nomogram for Predicting Postsurgical Intra-abdominal Infection in Gastric Cancer Patients: A Prospective Study. *J. Gastrointest. Surg.* **2018**, *22*, 421–429. [CrossRef] [PubMed]

152. Motoori, M.; Fujitani, K.; Sugimura, K.; Miyata, H.; Nakatsuka, R.; Nishizawa, Y.; Komatsu, H.; Miyazaki, S.; Komori, T.; Kashiwazaki, M.; et al. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer. *Oncology* **2018**, *95*, 281–287. [CrossRef]

153. McSorley, S.T.; Black, D.H.; Horgan, P.G.; McMillan, D.C. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. *Clin. Nutr.* **2018**, *37*, 1279–1285. [CrossRef] [PubMed]

154. van der Kroft, G.; Bours, D.M.J.L.; Janssen-Heijnen, D.M.; van Berlo, D.C.L.H.; Konsten, D.J.L.M. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: A comparison with the malnutrition screening tool. *Clin. Nutr. ESPEN* **2018**, *24*, 114–119. [CrossRef] [PubMed]

155. van Vugt, J.L.A.; Coebergh van den Braak, R.R.J.; Lalmahomed, Z.S.; Vrijland, W.W.; Dekker, J.W.T.; Zimmerman, D.D.E.; Vles, W.J.; Coene, P.-P.L.O.; IJzermans, J.N.M. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I–III colorectal cancer. *Eur. J. Surg. Oncol.* **2018**, *44*, 1354–1360. [CrossRef] [PubMed]

156. Williams, G.R.; Deal, A.M.; Shachar, S.S.; Walko, C.M.; Patel, J.N.; O'Neil, B.; McLeod, H.L.; Weinberg, M.S.; Choi, S.K.; Muss, H.B.; et al. The Impact of Skeletal Muscle on the Pharmacokinetics and Toxicity of 5-Fluorouracil in Colorectal Cancer. *Cancer Chemother. Pharmacol.* **2018**, *81*, 413–417. [CrossRef] [PubMed]

157. Zhang, W.; Lin, J.; Chen, W.; Huang, Y.; Wu, R.; Chen, X.; Lou, N.; Chi, C.; Hu, C.; Shen, X. Sarcopenic Obesity Is Associated with Severe Postoperative Complications in Gastric Cancer Patients Undergoing Gastrectomy: A Prospective Study. *J. Gastrointest. Surg.* **2018**, *22*, 1861–1869. [CrossRef] [PubMed]

158. Zhang, Y.; Wang, J.P.; Wang, X.L.; Tian, H.; Gao, T.T.; Tang, L.M.; Tian, F.; Wang, J.W.; Zheng, H.J.; Zhang, L.; et al. Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer. *Curr. Oncol.* **2018**, *25*, e411–e422. [CrossRef]

159. Okugawa, Y.; Yao, L.; Toiyama, Y.; Yamamoto, A.; Shigemori, T.; Yin, C.; Omura, Y.; Ide, S.; Kitajima, T.; Shimura, T.; et al. Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients. *Oncol. Rep.* **2018**, *39*, 1555–1564. [CrossRef] [PubMed]

160. Rier, H.N.; Jager, A.; Meinardi, M.C.; van Rosmalen, J.; Kock, M.C.J.M.; Westerweel, P.E.; Trajkovic, M.; Sleijfer, S.; Levin, M.-D. Severe sarcopenia might be associated with a decline of physical independence in older patients undergoing chemotherapeutic treatment. *Support. Care Cancer* **2018**, *26*, 1781–1789. [CrossRef] [PubMed]

161. Sato, S.; Kunisaki, C.; Suematsu, H.; Tanaka, Y.; Hiroshi, M.; Kosaka, T.; Yukawa, N.; Tanaka, K.; Sato, K.; Akiyama, H.; et al. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. *In Vivo* **2018**, *32*, 603–610. [CrossRef]

162. Stretch, C.; Aubin, J.-M.; Mickiewicz, B.; Leugner, D.; Al-manasra, T.; Tobola, E.; Salazar, S.; Sutherland, F.R.; Ball, C.G.; Dixon, E.; et al. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas. *PLoS ONE* **2018**, *13*, e0196235. [CrossRef] [PubMed]

163. Sugimoto, M.; Farnell, M.B.; Nagorney, D.M.; Kendrick, M.L.; Truty, M.J.; Smoot, R.L.; Chari, S.T.; Moynagh, M.R.; Petersen, G.M.; Carter, R.E.; et al. Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma. *J. Gastrointest. Surg.* **2018**, *22*, 831–839. [CrossRef]

164. Sui, K.; Okabayashi, T.; Iwata, J.; Morita, S.; Sumiyoshi, T.; Iiyama, T.; Shimada, Y. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy. *Surg. Today* **2018**, *48*, 545–551. [CrossRef]

165. Limpawattana, P.; Theerakulpisut, D.; Wirasorn, K.; Sookprasert, A.; Khuntikeo, N.; Chindaprasirt, J. The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients. *PLoS ONE* **2018**, *13*, e0204985. [CrossRef]

166. Caan, B.J.; Cespedes Feliciano, E.M.; Prado, C.M.; Alexeeff, S.; Kroenke, C.H.; Bradshaw, P.; Quesenberry, C.P.; Weltzien, E.K.; Castillo, A.L.; Olobatuyi, T.A.; et al. Association of Muscle and Adiposity Measured by Computed Tomography with Survival in Patients with Nonmetastatic Breast Cancer. *JAMA Oncol.* **2018**, *4*, 798–804. [CrossRef] [PubMed]

167. Ha, Y.; Kim, D.; Han, S.; Chon, Y.E.; Lee, Y.B.; Kim, M.N.; Lee, J.H.; Park, H.; Rim, K.S.; Hwang, S.G. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function. *Cancer Res. Treat.* **2018**, *50*, 843–851. [CrossRef] [PubMed]

168. Nakashima, Y.; Saeki, H.; Nakanishi, R.; Sugiyama, M.; Kurashige, J.; Oki, E.; Maehara, Y. Assessment of Sarcopenia as a Predictor of Poor Outcomes after Esophagectomy in Elderly Patients with Esophageal Cancer. *Ann. Surg.* **2018**, *267*, 1100–1104. [CrossRef] [PubMed]

169. Makiura, D.; Ono, R.; Inoue, J.; Fukuta, A.; Kashiwa, M.; Miura, Y.; Oshikiri, T.; Nakamura, T.; Kakeji, Y.; Sakai, Y. Impact of Sarcopenia on Unplanned Readmission and Survival after Esophagectomy in Patients with Esophageal Cancer. *Ann. Surg. Oncol.* **2018**, *25*, 456–464. [CrossRef] [PubMed]

170. Mason, R.J.; Boorjian, S.A.; Bhindi, B.; Rangel, L.; Frank, I.; Karnes, R.J.; Tollefson, M.K. The Association between Sarcopenia and Oncologic Outcomes after Radical Prostatectomy. *Clin. Genitourin. Cancer* **2018**, *16*, e629–e636. [CrossRef] [PubMed]

171. Begini, P.; Gigante, E.; Antonelli, G.; Carbonetti, F.; Iannicelli, E.; Anania, G.; Imperatrice, B.; Pellicelli, A.M.; Fave, G.D.; Marignani, M. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis. *Ann. Hepatol.* **2017**, *16*, 107–114. [CrossRef]
172. Black, D.; Mackay, C.; Ramsay, G.; Hamoodi, Z.; Nanthakumaran, S.; Park, K.G.M.; Loudon, M.A.; Richards, C.H. Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers. *Ann. Surg. Oncol.* **2017**, *24*, 2241–2251. [CrossRef] [PubMed]

173. Daly, L.E.; Power, D.G.; O'Reilly, Á.; Donnellan, P.; Cushen, S.J.; O'Sullivan, K.; Twomey, M.; Woodlock, D.P.; Redmond, H.P.; Ryan, A.M. The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma. *Br. J. Cancer* **2017**, *116*, 310–317. [CrossRef] [PubMed]

174. Endo, T.; Momoki, C.; Yamaoka, M.; Hachino, S.; Iwatani, S.; Kiyota, S.; Tanaka, H.; Habu, D. Validation of Skeletal Muscle Volume as a Nutritional Assessment in Patients with Gastric or Colorectal Cancer before Radical Surgery. *J. Clin. Med. Res.* **2017**, *9*, 844–859. [CrossRef] [PubMed]

175. Härter, J.; Orlandi, S.P.; Gonzalez, M.C. Nutritional and functional factors as prognostic of surgical cancer patients. *Support. Care Cancer* **2017**, *25*, 2525–2530. [CrossRef] [PubMed]

176. Heidelberger, V.; Goldwasser, F.; Kramkimel, N.; Jouinot, A.; Huillard, O.; Boudou-Rouquette, P.; Chanal, J.; Arrondeau, J.; Franck, N.; Alexandre, J.; et al. Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients. *Investig. New Drugs* **2017**, *35*, 436–441. [CrossRef] [PubMed]

177. Huang, D.-D.; Zhou, C.-J.; Wang, S.-L.; Mao, S.-T.; Zhou, X.-Y.; Lou, N.; Zhang, Z.; Yu, Z.; Shen, X.; Zhuang, C.-L. Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer. *Surgery* **2017**, *161*, 680–693. [CrossRef]

178. Imai, K.; Takai, K.; Watanabe, S.; Hanai, T.; Suetsugu, A.; Shiraki, M.; Shimizu, M. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume. *Nutrients* **2017**, *9*, 1054. [CrossRef] [PubMed]

179. Lou, N.; Chi, C.-H.; Chen, X.-D.; Zhou, C.-J.; Wang, S.-L.; Zhuang, C.-L.; Shen, X. Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study. *Eur. J. Surg. Oncol.* **2017**, *43*, 188–195. [CrossRef] [PubMed]

180. Cushen, S.J.; Power, D.G.; Teo, M.Y.; MacEneaney, P.; Maher, M.M.; McDermott, R.; O'Sullivan, K.; Ryan, A.M. Body Composition by Computed Tomography as a Predictor of Toxicity in Patients with Renal Cell Carcinoma Treated with Sunitinib. *Am. J. Clin. Oncol.* **2017**, *40*, 47–52. [CrossRef]

181. Cespedes Feliciano, E.M.; Kroenke, C.H.; Meyerhardt, J.A.; Prado, C.M.; Bradshaw, P.T.; Kwan, M.L.; Xiao, J.; Alexeeff, S.; Corley, D.; Weltzien, E.; et al. Association of Systemic Inflammation and Sarcopenia with Survival in Nonmetastatic Colorectal Cancer. *JAMA Oncol.* **2017**, *3*, e172319. [CrossRef]

182. Elliott, J.; Doyle, S.; Murphy, C.; King, S.; Guinan, E.; Beddy, P.; Ravi, N.; Reynolds, J. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer. *Ann. Surg.* **2017**, *266*, 822–830. [CrossRef] [PubMed]

183. Wendrich, A.W.; Swartz, J.E.; Bril, S.I.; Wegner, I.; de Graeff, A.; Smid, E.J.; de Bree, R.; Pothen, A.J. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. *Oral Oncol.* **2017**, *71*, 26–33. [CrossRef]

184. Bronger, H.; Hederich, P.; Hapfelmeier, A.; Metz, S.; Noël, P.B.; Kiechle, M.; Schmalfeldt, B. Sarcopenia in Advanced Serous Ovarian Cancer. *Int. J. Gynecol. Cancer* **2017**, *27*, 223–232. [CrossRef] [PubMed]

185. Ishihara, H.; Kondo, T.; Omae, K.; Takagi, T.; Iizuka, J.; Kobayashi, H.; Hashimoto, Y.; Tanabe, K. Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: A retrospective multi-institution study. *Int. J. Clin. Oncol.* **2017**, *22*, 136–144. [CrossRef]

186. Miyata, H.; Sugimura, K.; Motoori, M.; Fujiwara, Y.; Omori, T.; Yanagimoto, Y.; Ohue, M.; Yasui, M.; Miyoshi, N.; Tomokuni, A.; et al. Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer. *Anticancer Res.* **2017**, *37*, 3053–3059. [CrossRef] [PubMed]

187. Zhou, C.-J.; Zhang, F.-M.; Zhang, F.-Y.; Yu, Z.; Chen, X.-L.; Shen, X.; Zhuang, C.-L.; Chen, X.-X. Sarcopenia: A new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy. *J. Surg. Res.* **2017**, *211*, 137–146. [CrossRef] [PubMed]

188. Chemama, S.; Bayar, M.A.; Lanoy, E.; Ammari, S.; Stoclin, A.; Goéré, D.; Elias, D.; Raynard, B.; Antoun, S. Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer. *Ann. Surg. Oncol.* **2016**, *23*, 3891–3898. [CrossRef]

189. Grotenhuis, B.A.; Shapiro, J.; van Adrichem, S.; de Vries, M.; Koek, M.; Wijnhoven, B.P.L.; van Lanschot, J.J.B. Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome after Esophagectomy for Cancer. *World J. Surg.* **2016**, *40*, 2698–2704. [CrossRef]

190. Nishigori, T.; Okabe, H.; Tanaka, E.; Tsunoda, S.; Hisamori, S.; Sakai, Y. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. *J. Surg. Oncol.* **2016**, *113*, 678–684. [CrossRef] [PubMed]

191. Okumura, S.; Kaido, T.; Hamaguchi, Y.; Fujimoto, Y.; Kobayashi, A.; Iida, T.; Yagi, S.; Taura, K.; Hatano, E.; Uemoto, S. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. *Surgery* **2016**, *159*, 821–833. [CrossRef]

192. Pecorelli, N.; Carrara, G.; De Cobelli, F.; Cristel, G.; Damascelli, A.; Balzano, G.; Beretta, L.; Braga, M. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. *Br. J. Surg.* **2016**, *103*, 434–442. [CrossRef]
193. Park, I.; Choi, S.J.; Kim, Y.S.; Ahn, H.K.; Hong, J.; Sym, S.J.; Park, J.; Cho, E.K.; Lee, J.H.; Shin, Y.J.; et al. Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy. *Cancer Res. Treat.* **2016**, *48*, 1264-1273. [CrossRef]

194. Suzuki, Y.; Okamoto, T.; Fujishita, T.; Katsura, M.; Akamine, T.; Takamori, S.; Morodomi, Y.; Tagawa, T.; Shoji, F.; Maehara, Y. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer. *Lung Cancer* **2016**, *101*, 92-97. [CrossRef]

195. Takeoka, Y.; Sakatoku, K.; Miura, A.; Yamamura, R.; Araki, T.; Seura, H.; Okamura, T.; Koh, H.; Nakamae, H.; Hino, M.; et al. Prognostic Effect of Low Subcutaneous Adipose Tissue on Survival Outcome in Patients with Multiple Myeloma. *Clin. Lymphoma Myeloma Leuk.* **2016**, *16*, 434-441. [CrossRef]

196. Fukushima, H.; Nakanishi, Y.; Kataoka, M.; Tobisu, K.; Koga, F. Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy. *Cancer Med.* **2016**, *5*, 2213-2220. [CrossRef]

197. Go, S.; Park, M.J.; Song, H.; Kim, H.; Kang, M.H.; Lee, H.R.; Kim, Y.; Kim, R.B.; Lee, S.I.; Lee, G. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. *J. Cachexia Sarcopenia Muscle* **2016**, *7*, 567-576. [CrossRef] [PubMed]

198. Kumar, A.; Moynagh, M.R.; Multinu, F.; Cliby, W.A.; McGree, M.E.; Weaver, A.L.; Young, P.M.; Bakkum-Gamez, J.N.; Langstraat, C.L.; Dowdy, S.C.; et al. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer. *Gynecol. Oncol.* **2016**, *142*, 311-316. [CrossRef] [PubMed]

199. Pędziwiatr, M.; Pisarska, M.; Major, P.; Grochowska, A.; Matłok, M.; Przęczek, K.; Stefura, T.; Budzyński, A.; Klęk, S. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. *Eur. J. Surg. Oncol.* **2016**, *42*, 779-787. [CrossRef] [PubMed]

200. Rollins, K.E.; Tewari, N.; Ackner, A.; Awwad, A.; Madhusudan, S.; Macdonald, I.A.; Fearon, K.C.H.; Lobo, D.N. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. *Clin. Nutr.* **2016**, *35*, 1103-1109. [CrossRef]

201. Yabusaki, N.; Fujii, T.; Yamada, S.; Suzuki, K.; Sugimoto, H.; Kanda, M.; Nakayama, G.; Koike, M.; Fujiwara, M.; Kodera, Y. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection. *Int. J. Surg.* **2016**, *30*, 136-142. [CrossRef]

202. Buettner, S.; Wagner, D.; Kim, Y.; Margonis, G.A.; Makary, M.A.; Wilson, A.; Sasaki, K.; Amini, N.; Gani, F.; Pawlik, T.M. Inclusion of Sarcopenia Outperforms the Modified Frailty Index in Predicting 1-Year Mortality among 1,326 Patients Undergoing Gastrointestinal Surgery for a Malignant Indication. *J. Am. Coll. Surg.* **2016**, *222*, 397-407. [CrossRef] [PubMed]

203. Amini, N.; Spolverato, G.; Gupta, R.; Margonis, G.A.; Kim, Y.; Wagner, D.; Rezaee, N.; Weiss, M.J.; Wolfgang, C.L.; Makary, M.M.; et al. Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: A New Tool to Assess Sarcopenia. *J. Gastrointest. Surg.* **2015**, *19*, 1593-1602. [CrossRef] [PubMed]

204. Anandavadivelan, P.; Brismar, T.B.; Nilsson, M.; Johar, A.M.; Martin, L. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. *Clin. Nutr.* **2015**, *35*, 724-730. [CrossRef]

205. Fukuda, Y.; Yamamoto, K.; Hirao, M.; Nishikawa, K.; Nagatsuma, Y.; Nakayama, T.; Tanikawa, S.; Maeda, S.; Uemura, M.; Miyake, M.; et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. *Gastric Cancer* **2015**, *19*, 986-993. [CrossRef]

206. Huang, D.-D.; Wang, S.-L.; Zhuang, C.-L.; Zheng, B.-S.; Lu, J.-X.; Chen, F.-F.; Zhou, C.-J.; Shen, X.; Yu, Z. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. *Colorectal Dis.* **2015**, *17*, O256-O264. [CrossRef]

207. Ida, S.; Watanabe, M.; Yoshida, N.; Baba, Y.; Umezaki, N.; Harada, K.; Karashima, R.; Imamura, Y.; Iwagami, S.; Baba, H. Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer. *Ann. Surg. Oncol.* **2015**, *22*, 4432-4437. [CrossRef] [PubMed]

208. Kim, E.Y.; Kim, Y.S.; Park, I.; Ahn, H.K.; Cho, E.K.; Jeong, Y.M. Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer. *J. Thorac. Oncol.* **2015**, *10*, 1795-1799. [CrossRef] [PubMed]

209. Levolger, S.; van Vledder, M.G.; Muslem, R.; Koek, M.; Niessen, W.J.; de Man, R.A.; de Bruin, R.W.F.; Ijzermans, J.N.M. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. *J. Surg. Oncol.* **2015**, *112*, 208-213. [CrossRef] [PubMed]

210. Reisinger, K.W.; van Vugt, J.L.A.; Tegels, J.J.W.; Snijders, C.; Hulsewé, K.W.E.; Hoofwijk, A.G.M.; Stoot, J.H.; Von Meyenfeldt, M.F.; Beets, G.L.; Derikx, J.P.M.; et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. *Ann. Surg.* **2015**, *261*, 345-352. [CrossRef]

211. Tamandl, D.; Paireder, M.; Asari, R.; Baltzer, P.A.; Schoppmann, S.F.; Ba-Ssalamah, A. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. *Eur. Radiol.* **2016**, *26*, 1359-1361. [CrossRef]

212. Tegels, J.J.W.; van Vugt, J.L.A.; Reisinger, K.W.; Hulsewé, K.W.E.; Hoofwijk, A.G.M.; Derikx, J.P.M.; Stoot, J.H.M.B. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. *J. Surg. Oncol.* **2015**, *112*, 403-407. [CrossRef]
213. Voron, T.; Tselikas, L.; Pietrasz, D.; Pigneur, F.; Laurent, A.; Compagnon, P.; Salloum, C.; Luciani, A.; Azoulay, D. Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma. *Ann. Surg.* **2015**, *261*, 1173–1183. [CrossRef] [PubMed]

214. Lodewick, T.M.; van Nijnatten, T.J.A.; van Dam, R.M.; van Mierlo, K.; Dello, S.A.W.G.; Neumann, U.P.; Olde Damink, S.W.M.; Dejong, C.H.C. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? *HPB* **2015**, *17*, 438–446. [CrossRef] [PubMed]

215. Tan, B.H.L.; Brammer, K.; Randhawa, N.; Welch, N.T.; Parsons, S.L.; James, E.J.; Catton, J.A. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. *Eur. J. Surg. Oncol.* **2015**, *41*, 333–338. [CrossRef]

216. Wang, S.-L.; Zhuang, C.-L.; Huang, D.-D.; Pang, W.-Y.; Lou, N.; Chen, F.-F.; Zhou, C.-J.; Shen, X.; Yu, Z. Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study. *Ann. Surg. Oncol.* **2015**, *23*, 556–564. [CrossRef]

217. van Vugt, J.L.A.; Braam, H.J.; van Oudheusden, T.R.; Vestering, A.; Bollen, T.L.; Wiezer, M.J.; de Hingh, I.H.J.T.; van Ramshorst, B.; Boerma, D. Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer. *Ann. Surg. Oncol.* **2015**, *22*, 3625–3631. [CrossRef] [PubMed]

218. Gonzalez, M.C.; Pastore, C.A.; Orlandi, S.P.; Heymsfield, S.B. Obesity paradox in cancer: New insights provided by body composition. *Am. J. Clin. Nutr.* **2014**, *99*, 999–1005. [CrossRef] [PubMed]

219. Barret, M.; Antoun, S.; Dalban, C.; Malka, D.; Mansourbakht, T.; Zaanan, A.; Latko, E.; Taieb, J. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. *Nutr. Cancer* **2014**, *66*, 583–589. [CrossRef]

220. Harimoto, N.; Shirabe, K.; Yamashita, Y.-I.; Ikegami, T.; Yoshizumi, T.; Soejima, Y.; Ikeda, T.; Maehara, Y.; Nishie, A.; Yamanaka, T. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. *Br. J. Surg.* **2013**, *100*, 1523–1530. [CrossRef]

221. Huillard, O.; Mir, O.; Peyromaure, M.; Tlemsani, C.; Giroux, J.; Boudou-Rouquette, P.; Ropert, S.; Delongchamps, N.B.; Zerbib, M.; Goldwasser, F. Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. *Br. J. Cancer* **2013**, *108*, 1034–1041. [CrossRef]

222. Veasey-Rodrigues, H.; Parsons, H.A.; Janku, F.; Naing, A.; Wheler, J.J.; Tsimberidou, A.M.; Kurzrock, R. A pilot study of temsirolimus and body composition. *J. Cachexia Sarcopenia Muscle* **2013**, *4*, 259–265. [CrossRef] [PubMed]

223. Veasey Rodrigues, H.; Baracos, V.E.; Wheler, J.J.; Parsons, H.A.; Hong, D.S.; Naing, A.; Fu, S.; Falchoock, G.; Tsimberidou, A.M.; Piha-Paul, S.; et al. Body composition and survival in the early clinical trials setting. *Eur. J. Cancer* **2013**, *49*, 3068–3075. [CrossRef] [PubMed]

224. Meza-Junco, J.; Montano-Loza, A.J.; Baracos, V.E.; Prado, C.M.M.; Bain, V.G.; Beaumont, C.; Esfandiari, N.; Lieffers, J.R.; Sawyer, M.B. Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma. *J. Clin. Gastroenterol.* **2013**, *47*, 861–870. [CrossRef] [PubMed]

225. Lieffers, J.R.; Bathe, O.F.; Fassbender, K.; Winget, M.; Baracos, V.E. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. *Br. J. Cancer* **2012**, *107*, 931–936. [CrossRef]

226. Mir, O.; Coriat, R.; Boudou-Rouquette, P.; Ropert, S.; Durand, J.-P.; Cessot, A.; Mallet, V.; Sogni, P.; Chaussade, S.; Pol, S.; et al. Gemcitabine and oxaliplatin as second-line treatment in patients with hepatocellular carcinoma pre-treated with sorafenib. *Med. Oncol.* **2012**, *29*, 2793–2799. [CrossRef]

227. Parsons, H.A.; Baracos, V.E.; Dhillon, N.; Hong, D.S.; Kurzrock, R. Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. *PLoS ONE* **2012**, *7*, e29330. [CrossRef]

228. Parsons, H.A.; Tsimberidou, A.M.; Pontikos, M.; Fu, S.; Hong, D.; Wen, S.; Baracos, V.E.; Kurzrock, R. Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy. *Nutr. Cancer* **2012**, *64*, 206–217. [CrossRef] [PubMed]

229. van Vledder, M.G.; Levolger, S.; Ayez, N.; Verhoef, C.; Tran, T.C.K.; Ijzermans, J.N.M. Body composition and outcome in patients undergoing resection of colorectal liver metastases. *Br. J. Surg.* **2012**, *99*, 550–557. [CrossRef]

230. Dalal, S.; Hui, D.; Bidaut, L.; Lem, K.; Del Fabbro, E.; Crane, C.; Reyes-Gibby, C.C.; Bedi, D.; Bruera, E. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: A pilot study. *J. Pain Symptom Manag.* **2012**, *44*, 181–191. [CrossRef] [PubMed]

231. Antoun, S.; Birdsell, L.; Sawyer, M.B.; Venner, P.; Escudier, B.; Baracos, V.E. Association of Skeletal Muscle Wasting with Treatment with Sorafenib in Patients with Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study. *J. Clin. Oncol.* **2010**, *28*, 1054–1060. [CrossRef] [PubMed]

232. Tan, B.H.L.; Birdsell, L.A.; Martin, L.; Baracos, V.E.; Fearon, K.C.H. Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer. *Clin. Cancer Res.* **2009**, *15*, 6973–6979. [CrossRef] [PubMed]

233. Prado, C.M.M.; Baracos, V.E.; McCargar, L.J.; Reiman, T.; Mourtzakis, M.; Tonkin, K.; Mackey, J.R.; Koski, S.; Pituskin, E.; Sawyer, M.B. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment. *Clin. Cancer Res.* **2009**, *15*, 2920–2926. [CrossRef] [PubMed]

234. Prado, C.M.; Lieffers, J.R.; McCargar, L.J.; Reiman, T.; Sawyer, M.B.; Martin, L.; Baracos, V.E. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. *Lancet Oncol.* **2008**, *9*, 629–635. [CrossRef]
235. Paireder, M.; Asari, R.; Kristo, I.; Rieder, E.; Tamandl, D.; Ba-Ssalamah, A.; Schoppmann, S. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. *Eur. J. Surg. Oncol. (EJSO)* **2016**, *43*, 478-484. [CrossRef] [PubMed]

236. Nakano, J.; Fukushima, T.; Tanaka, T.; Fu, J.B.; Morishita, S. Physical function predicts mortality in patients with cancer: A systematic review and meta-analysis of observational studies. *Support. Care Cancer* **2021**, *29*, 5623-5634. [CrossRef] [PubMed]

237. Williams, G.R.; Al-Obaidi, M.; Dai, C.; Bhatia, S.; Giri, S. SARC-F for screening of sarcopenia among older adults with cancer. *Cancer* **2021**, *127*, 1469-1475. [CrossRef] [PubMed]

238. Liao, C.-D.; Tsauo, J.-Y.; Wu, Y.-T.; Cheng, C.-P.; Chen, H.-C.; Huang, Y.-C.; Chen, H.-C.; Liou, T.-H. Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults: A systematic review and meta-analysis. *Am. J. Clin. Nutr.* **2017**, *106*, 1078-1091. [CrossRef] [PubMed]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.